Akso Health Group Sponsored ADR (NASDAQ:AHG – Get Free Report)’s stock price gapped up before the market opened on Thursday . The stock had previously closed at $1.44, but opened at $1.60. Akso Health Group shares last traded at $1.54, with a volume of 1,451 shares traded.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Akso Health Group in a research report on Friday, July 17th. Wall Street Zen upgraded shares of Akso Health Group to a “sell” rating in a research report on Saturday, May 2nd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has an average rating of “Sell”.
Check Out Our Latest Stock Report on Akso Health Group
Akso Health Group Stock Up 5.0%
Hedge Funds Weigh In On Akso Health Group
An institutional investor recently bought a new position in Akso Health Group stock. SmartHarvest Portfolios LLC acquired a new stake in Akso Health Group Sponsored ADR (NASDAQ:AHG – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 16,748 shares of the company’s stock, valued at approximately $27,000. 1.21% of the stock is currently owned by institutional investors and hedge funds.
Akso Health Group Company Profile
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc and changed its name to Akso Health Group in December 2021.
Recommended Stories
- Five stocks we like better than Akso Health Group
- Is Buying a Launch Company AST SpaceMobile’s Next Vertical Integration Move?
- AMD’s $5 Billion Anthropic Deal Could Redraw the AI Chip Battle
- The 2026 Blueprint: 6 Stocks for a Brand New Portfolio
- Philip Morris Trimmed Guidance, But Its Growth Story Looks Unshaken
Receive News & Ratings for Akso Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akso Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
